Howard Coleman on CSL Ltd (CSL)
Aging populations will pave the way for CSL profit growth. Howard Coleman is confident that this biotech’s large-scale plasma collection hiccups are short-term.
Aging populations will pave the way for CSL profit growth. Howard Coleman is confident that this biotech’s large-scale plasma collection hiccups are short-term.